Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Lauer

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Circulation|August 29, 2001
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary interventionD P Chew, D L Bhatt, M A Robbins, et al.
The American Journal of Medicine|May 7, 1999
The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study GroupT H Marwick, L J Shaw, M S Lauer, et al.
The American Journal of Cardiology|March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ G Peterson, E J Topol, M T Roe, et al.
The American Journal of Cardiology|June 27, 2000
Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study GroupL J Shaw, R Hachamovitch, G V Heller, et al.
Journal of the American College of Cardiology|March 18, 1999
The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study GroupL J Shaw, R Hachamovitch, D S Berman, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Circulation|August 29, 2001
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary interventionD P Chew, D L Bhatt, M A Robbins, et al.
The American Journal of Medicine|May 7, 1999
The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study GroupT H Marwick, L J Shaw, M S Lauer, et al.
The American Journal of Cardiology|March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ G Peterson, E J Topol, M T Roe, et al.
The American Journal of Cardiology|June 27, 2000
Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study GroupL J Shaw, R Hachamovitch, G V Heller, et al.
Journal of the American College of Cardiology|March 18, 1999
The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study GroupL J Shaw, R Hachamovitch, D S Berman, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Pageof 9